Landmark Study Published in New England Journal o...( New York Hospital Queens One of Clini...),Health

New York Hospital Queens One of Clinical Sites, Research Director is Co-Author

FLUSHING, N.Y., June 9 /PRNewswire/ -- One of the world's most respected medical journals, the New England Journal of Medicine, is publishing a landmark study this week that explores treatments for people with both Type 2 diabetes and coronary artery disease. The Lang Research and Education Center of New York Hospital Queens was one of the sites that conducted this study.

The study, known as BARI 2D, (Bypass Angioplasty Revascularization Investigation 2 Diabetes) was also presented yesterday in New Orleans at the American Diabetes Association 69th Scientific Sessions -- a national medical conference. The results demonstrated that there is no difference in mortality among patients with type 2 diabetes and stable heart disease who received prompt bypass surgery or angioplasty compared to drug therapy alone. The results also showed that while prompt bypass in patients with more severe heart disease did not lower mortality, it lowered their risk of subsequent major cardiac events.

Phyllis August, M.D., M.P.H., director, Lang Research Center for Research and Education, New York Hospital Queens, served as a co-investigator and co-author of the study. She called the results, "very exciting and good news." "More than 20 million Americans suffer from type 2 diabetes and many of these people also have heart disease. This deadly disease duo is affecting more and more people at increasingly younger ages."

According to Dr. August, the message to patients is a strong one; "you can modify this disease with careful attention to prevention, managing risk factors and by following your doctor's instructions."

"The study's results provide needed guidance about which approaches can best help these patients," said August. They also indicate that when a patient with type 2 diabetes has more severe heart
'/>"/>